Bipolar needle with adjustable electrodes for geometrically controlled thermal ablation of biological tissue

The ablation probe with adjustable electrodes and a signal generator provides precise geometric control over thermal ablation, addressing the need for flexible bipolar treatments by adjusting electrode positions and treatment parameters for targeted tissue ablation.

JP2024541563AActive Publication Date: 2024-11-08BOSTON SCIENTIFIC SCIMED INC
View PDF 7 Cites 0 Cited by

Patent Information

Application Number
JP2024531586
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-11-29
Filing Date
2022-11-29
Publication Date
2024-11-08
Estimated Expiration
2042-11-29

AI Technical Summary

Technical Problem

There is a need for new and alternative bipolar ablation treatments that allow for geometrically controlled thermal ablation of biological tissue, as existing methods lack flexibility and precision in targeting specific tissue regions.

Method used

The use of an ablation probe with adjustable electrodes, including a shaft electrode and a needle electrode, which are movable and lockable relative to each other, allowing for precise control of exposed surface areas and distances, combined with a signal generator that senses impedance and temperature to adjust treatment parameters.

Benefits of technology

Enables precise and controlled thermal ablation by adjusting electrode surface areas and distances, ensuring targeted tissue damage with minimal collateral damage, and allowing for both thermal and non-thermal ablation modalities to be applied effectively.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024541563000001_ABST
    Figure 2024541563000001_ABST
Patent Text Reader

Abstract

Methods, devices, and systems for ablation therapy. A configurable ablation probe includes at least two electrodes whose surface areas are user-manipulable and subsequently fixable. Some methods include adjusting the relative surface areas in a sequence of ablation steps to preferentially create lesions closer to one of the electrodes. Some methods include adjusting the position of one of the electrodes during therapy delivery to generate an elongated lesion.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present disclosure relates to a bipolar needle with adjustable electrodes for geometrically controlled thermal ablation of biological tissue. [Background technology]

[0002] Electrical stimulation can be applied to ablate tissue in various forms. For example, thermal RF ablation and non-thermal irreversible electroporation (IRE) can be used. Although several techniques are currently available, new and alternative methods for targeted therapy are desirable. Summary of the Invention

[0003] The present inventors have recognized, inter alia, that a problem to be solved is the need for new and / or alternative bipolar ablation therapy methods that may employ adjustable electrodes on an ablation probe or catheter.

[0004] A first illustrative and non-limiting example takes the form of an ablation probe having a proximal end and a distal end, the probe comprising an outer sheath of a non-conductive material, an inner sheath of a non-conductive material, a shaft electrode disposed between the inner and outer sheaths, a needle electrode disposed within the inner sheath, a first locking hub configured to selectively lock the relative position of the outer sheath with respect to the shaft electrode, a second locking hub configured to selectively lock the relative position of the shaft electrode with respect to the inner sheath, and a third locking hub configured to selectively lock the relative position of the inner sheath with respect to the needle electrode.

[0005] Additionally or alternatively, the needle electrode, the inner sheath, the shaft electrode, and the outer sheath are each movable relative to one another when not locked to any of the locking hubs. Additionally or alternatively, the needle electrode includes a tissue-piercing distal tip. Additionally or alternatively, the third locking hub can facilitate defining an exposed surface area of ​​the needle electrode and the first locking hub can facilitate defining an exposed surface area of ​​the shaft electrode such that, in use, a user can lock the first and third locking hubs while moving the needle electrode having a fixed surface area relative to the shaft electrode also having a fixed surface area. Additionally or alternatively, the ablation probe can include a means for electrically indicating a change in the exposed surface area of ​​at least one of the shaft electrode and the needle electrode. Additionally or alternatively, the ablation probe can include a means for electrically indicating a change in the distance between the shaft electrode and the needle electrode. Additionally or alternatively, the needle electrode includes a lumen through an interior of the needle electrode to allow fluid to be injected. Additionally or alternatively, the outer sheath includes a lumen passing through the interior of the outer sheath to allow fluid to be infused.

[0006] Additionally or alternatively, the ablation probe can be included in a system for ablation that also includes a signal generator adapted for electrical connection to each of the needle and shaft electrodes, the signal generator configured to sense an impedance between the needle and shaft electrodes during treatment delivery to maintain a treatment current as the needle and shaft electrodes are moved relative to each other. The treatment current can be a constant current. Additionally or alternatively, the system or probe can include a temperature sensor associated with at least one of the shaft or needle electrodes. Additionally or alternatively, the ablation probe can be included in a system for ablation that also includes a signal generator adapted for electrical connection to each of the needle and shaft electrodes, the signal generator configured to sense an impedance between the needle and shaft electrodes during treatment delivery, obtain a temperature signal from the temperature sensor, and adjust a treatment voltage in response to the temperature signal and the impedance signal.

[0007] Additionally or alternatively, the signal generator is configured to operate to sense temperature and impedance at the initiation of therapy output, maintain or increase voltage until the sensed temperature reaches a temperature threshold, measure impedance and voltage and store the target current when the sensed temperature reaches the temperature threshold, monitor impedance to maintain the target current after the temperature threshold is reached, and reduce the target current if the sensed temperature rises above the temperature threshold.

[0008] Additionally or alternatively, the signal generator is configured to sense the distance between the electrodes and the surface area of ​​the electrodes by linking to either locking hub. Additionally or alternatively, the signal generator is configured to adjust the sensed impedance to take into account the distance between the electrodes and / or the surface area of ​​the electrodes. Additionally or alternatively, the signal generator is configured to provide an ablation signal for irreversible electroporation and thermal ablation.

[0009] Another illustrative but non-limiting example takes the form of a method of ablating a tissue region using a treatment probe having a shaft with a proximal and distal ends and a plurality of treatment delivery electrodes at the distal end, the method including the steps of inserting the treatment probe to position a distal end of the shaft at a desired location, the distal end of the shaft including a shaft electrode having an exposed portion proximal to the distal end of the shaft, the surface area of ​​the exposed portion of the shaft electrode being adjustable; advancing a needle electrode from the shaft to a desired location to control the surface area of ​​the exposed portion of the needle electrode by manipulating a needle electrode sheath that adjustably exposes a portion of the needle electrode; creating a first lesion adjacent to the shaft electrode by delivering a first treatment while the surface area of ​​the exposed portion of the needle electrode exceeds the surface area of ​​the exposed portion of the shaft electrode; and creating a second lesion adjacent to the needle electrode by delivering a second treatment while the surface area of ​​the exposed portion of the shaft electrode exceeds the surface area of ​​the exposed portion of the needle electrode.

[0010] Additionally or alternatively, the method may further include manipulating an exposed portion of the needle electrode between the steps of delivering the first treatment and the second treatment.Additionally or alternatively, the method may further include manipulating an exposed portion of the shaft electrode between the steps of delivering the first treatment and the second treatment.

[0011] Additionally or alternatively, the treatment probe is configured such that a position of the exposed portion of the shaft electrode is adjustable relative to a distal end of the treatment probe, and the method further includes adjusting a position of the exposed portion of the shaft electrode between the steps of delivering the first treatment and delivering the second treatment. Additionally or alternatively, the first treatment takes the form of a thermal RF ablation treatment and the second treatment takes the form of a thermal RF ablation treatment.

[0012] Additionally or alternatively, the treatment probe includes an outer sheath of non-conductive material, a needle electrode sheath also of non-conductive material, a shaft electrode disposed between the needle electrode sheath and the outer sheath, a needle electrode disposed within the needle electrode sheath, a first locking hub configured to selectively lock the relative position of the outer sheath with respect to the shaft electrode, a second locking hub configured to selectively lock the relative position of the shaft electrode with respect to the needle electrode sheath, and a third locking hub configured to selectively lock the relative position of the needle electrode sheath with respect to the needle electrode.

[0013] Additionally or alternatively, the method may further include locking the first locking hub and the third locking hub prior to delivering the first treatment, unlocking at least one of the first locking hub or the third locking hub after delivering the first treatment to manipulate an exposed surface area of ​​at least one of the shaft electrode or the needle electrode, and relocking at least one of the first locking hub or the third locking hub after manipulating the exposed surface area of ​​at least one of the shaft electrode or the needle electrode before delivering the second treatment.

[0014] Another illustrative, non-limiting example takes the form of a method of ablating a tissue region using an ablation probe having a shaft with a proximal and distal ends and a plurality of treatment delivery electrodes at the distal end, the method including the steps of inserting the ablation probe to position a distal end of the shaft at a desired location, the distal end of the shaft including a shaft electrode having an exposed portion proximal to the distal end of the shaft, the surface area of ​​the exposed portion of the shaft electrode being adjustable; advancing a needle electrode from the shaft to a desired location to control the surface area of ​​the exposed portion of the needle electrode by manipulating a needle electrode sheath that adjustably exposes a portion of the needle electrode; delivering a first treatment while the surface area of ​​the exposed portion of the shaft electrode exceeds the surface area of ​​the exposed portion of the needle electrode, thereby creating a first lesion adjacent to the needle electrode; and expanding the first lesion longitudinally relative to an axis of the needle electrode by retracting the needle electrode from the desired location into the shaft while maintaining the exposed surface area of ​​the needle electrode during delivery of the first treatment.

[0015] Additionally or alternatively, the treatment probe includes an outer sheath of non-conductive material, a needle electrode sheath also of non-conductive material, a shaft electrode disposed between the needle electrode sheath and the outer sheath, a needle electrode disposed within the needle electrode sheath, a first locking hub configured to selectively lock the relative position of the outer sheath with respect to the shaft electrode, a second locking hub configured to selectively lock the relative position of the shaft electrode with respect to the needle electrode sheath, and a third locking hub configured to selectively lock the relative position of the needle electrode sheath with respect to the needle electrode.

[0016] Additionally or alternatively, the method may further include a step of locking the first locking hub and the third locking hub to secure the exposed surface areas of the shaft electrode and the needle electrode, respectively, prior to delivering the first treatment, while leaving the second locking hub unlocked to allow retraction of the needle electrode into the shaft from a desired position.

[0017] Additionally or alternatively, the method may further include reducing a power level of the first treatment as the needle electrode is retracted into the shaft from the desired location. Additionally or alternatively, the method may further include sensing an impedance between the needle electrode and the shaft electrode, sensing at least one temperature at a location adjacent the needle electrode, and adjusting a power level of the first treatment as the needle electrode is retracted into the shaft from the desired location in response to the sensed impedance and the at least one temperature.

[0018] Another illustrative but non-limiting example takes the form of a method of ablating a tissue region using an ablation probe having a shaft with a proximal and distal ends and a plurality of treatment delivery electrodes at the distal end, the method including the steps of inserting the ablation probe to position a distal end of the shaft at a desired location, the distal end of the shaft including a shaft electrode having an exposed portion proximal to the distal end of the shaft, the surface area of ​​the exposed portion of the shaft electrode being adjustable; advancing a needle electrode from the shaft to a desired location to control the surface area of ​​the exposed portion of the needle electrode by manipulating a needle electrode sheath that adjustably exposes a portion of the needle electrode; delivering a first treatment while the surface area of ​​the exposed portion of the shaft electrode exceeds the surface area of ​​the exposed portion of the needle electrode, thereby creating a first lesion adjacent to the needle electrode; and expanding the first lesion longitudinally relative to an axis of the needle electrode by advancing the needle electrode out of the shaft from the desired location while maintaining the exposed surface area of ​​the needle electrode during delivery of the first treatment.

[0019] Additionally or alternatively, the treatment probe includes an outer sheath of non-conductive material, a needle electrode sheath also of non-conductive material, a shaft electrode disposed between the needle electrode sheath and the outer sheath, a needle electrode disposed within the needle electrode sheath, a first locking hub configured to selectively lock the relative position of the outer sheath with respect to the shaft electrode, a second locking hub configured to selectively lock the relative position of the shaft electrode with respect to the needle electrode sheath, and a third locking hub configured to selectively lock the relative position of the needle electrode sheath with respect to the needle electrode.

[0020] Additionally or alternatively, the method may further include the step of locking the first locking hub and the third locking hub to secure the exposed surface areas of the shaft electrode and the needle electrode, respectively, prior to delivering the first treatment, while leaving the second locking hub unlocked to allow advancement of the needle electrode during the first treatment.

[0021] Additionally or alternatively, the locking hub is provided on an assembly that includes a visible indicator that indicates how much the needle electrode is exposed, and the method includes using the visible indicator to determine how much the needle electrode is exposed. Additionally or alternatively, the locking hub is provided on an assembly that includes a visible indicator that indicates how much the shaft electrode is exposed, and the method includes using the visible indicator to determine how much the shaft electrode is exposed. Additionally or alternatively, the method may further include increasing a power level of the first treatment as the needle electrode advances. Additionally or alternatively, the first treatment is an RF ablation treatment.

[0022] Additionally or alternatively, the method may further include sensing impedance between the needle electrode and the shaft electrode, sensing at least one temperature at a location adjacent the needle electrode, and adjusting a power level of the first treatment as the needle electrode advances in response to the sensed impedance and the at least one temperature.

[0023] The intent of this summary is to provide an introduction to the subject matter of this patent application. It is not intended to provide an exclusive or exhaustive description. The Detailed Description is included to provide further information about this patent application.

[0024] In these drawings, which are not necessarily drawn to scale, like numerals may describe like components in different figures. Like numerals with different letter suffixes may represent different instances of like components. These drawings illustrate generally, by way of example, but not by way of limitation, various embodiments discussed in the present document. [Brief description of the drawings]

[0025] [Figure 1] FIG. 1 illustrates an exemplary ablation system. [Diagram 2] 1A-1D show aspects of the distal end of an ablation probe. [Diagram 3] 1A-1D show aspects of the distal end of an ablation probe. [Figure 4] 1A-1D show aspects of the distal end of an ablation probe. [Diagram 5] FIG. 1 illustrates an exemplary ablation step. [Figure 6] FIG. 1 illustrates an exemplary ablation step. [Figure 7] FIG. 1 illustrates an exemplary ablation step. [Figure 8] FIG. 13 illustrates an additional ablation procedure step with additional detail on the proximal end of the ablation probe. [Figure 9] FIG. 13 illustrates an additional ablation procedure step with additional detail on the proximal end of the ablation probe. [Figure 10] 1 is a process flow diagram in block form for an exemplary ablation procedure. [Figure 11] 1 is a process flow diagram in block form for an exemplary ablation procedure. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0026] FIG. 1 illustrates an exemplary ablation system. The system includes an ablation probe 100 adapted for insertion into tissue of a patient 110 to access a target area 112, which may be, for example, an organ, diseased tissue, a tumor, etc. At the distal end (the end inserted into the patient) is a tissue piercing electrode 102. Instead of the single electrode 102 shown, multiple tissue piercing electrodes can also be used. For example, multiple tissue piercing electrodes in the form of an array can use designs such as those shown in U.S. Patent Application Publication No. 2019 / 0223943 and / or U.S. Patent Nos. 5,855,576 and 6,638,277, the disclosures of which are incorporated herein by reference to illustrate ablation probe designs and to describe various features and methods of their use. The tissue piercing electrode 102 can be advanced and retracted relative to the distal end of the ablation probe 100. Further details regarding the distal portion of the exemplary ablation probe 100 are described below.

[0027] The ablation probe 100 is coupled to a signal generator 108 by wires 106. The signal generator may include control circuitry, including digital and / or analog circuitry, for shaping / defining an output waveform, which may be, for example, but is not limited to, a square wave, a sine wave, or any other suitable output. The signal generator may be battery powered, but in most cases will draw line power, such as by being plugged into a wall outlet. The signal generator 108 may include circuitry therein for measuring the output impedance of the signal delivered through the probe 100. For example, a microcontroller or microprocessor may be provided, as well as sample / hold circuitry, measurement circuitry, comparators, filtering circuitry, operational amplifiers, etc., for receiving and measuring the signal. The output circuitry may include, for example, but is not limited to, an output H-bridge for high power output, or use other architectures, as well as any other suitable switching or resonant circuitry, as desired. The output circuitry may include, for example, IGBT transistors for high power systems, although other electronic components may be used with known tradeoffs between speed, rise time, current capacity, cost, size, and the like. The signal generator 108 may also be configured to connect to one or more temperature sensors, such as thermistors or other temperature sensing devices, located in or on the ablation probe 100, to obtain or receive signals from the one or more temperature sensors and interpret the received data to allow for measuring and / or monitoring the temperature at selected locations. For example, in the case of thermal ablation, a range of target temperatures (50-100° C., 55-80° C., 60-70° C., etc.) may be defined to generate a therapeutic output that will cause a desired amount of cell death without undue side effects or danger. The target temperature may be maintained for a desired period of time (e.g., 10-60 seconds, or 20-30 seconds, as desired). For non-thermal ablation such as IRE, a temperature sensor can be used to ensure that the tissue temperature remains within a relatively low range (<50° C., <42° C., etc.).Some examples of ablation generators can be found in U.S. Patent Application Publication Nos. 20210228260, 20210106374, 20200289827, 20200289188, and / or 20200289185, the disclosures of which are incorporated herein by reference. The signal generator 108 can also take other forms.

[0028] As used herein, monopolar therapy refers to a therapy in which a return electrode, such as patch electrode 120, is placed on patient 110, such as on the patient's skin, such that a current flows through the tissue between an electrode on or extending from ablation probe 100 and return electrode 120, as determined by the electric field generated between the electrodes. Bipolar therapy is a therapy in which two electrodes, both inserted relatively close to each other, pass a current between them, such as between electrode 102 and an electrode on ablation probe 100 (see FIGS. 2-4). Patch electrode 120 can still be applied as an indifferent or ground electrode, but almost all of the current in a bipolar therapy passes between the inserted electrodes.

[0029] 2-4 show various aspects of the distal end of an ablation probe. A particular probe distal end configuration is shown at 200. An outer sheath 210 is provided over a shaft electrode 212 which in turn is over an inner sheath 214. A needle electrode 216 is located within the inner sheath. The outer sheath 210 and inner sheath 214 can be made of any suitable medical grade insulating material. Examples include, but are not limited to, polyimide, polyether block amide, and other insulating polymers. The shaft electrode 212 and needle electrode 216 can be made of any suitable material. Suitable materials include, but are not limited to, stainless steel, gold, titanium, and other conductive metals, as well as optionally conductive polymers, as needed.

[0030] The outer sheath 210 may take the form of a hollow tube having one or more lumens therein. The outer sheath 210 may have multiple longitudinal sections attached together, if desired. The shaft electrode 212 is movable relative to the outer sheath 210, as well as the inner sheath 214. The shaft electrode 212 itself may also be a tubular element, such as a cylindrical electrode or hypotube, having a lumen therethrough. In some embodiments, the shaft electrode 212 includes a first section, including that portion represented by a tubular distal portion. The shaft electrode 212 also includes a second, more proximal portion, which takes the form of an elongated conductive push / pull wire that may reduce friction associated with movement of the shaft electrode 212.

[0031] The inner sheath may also be a hollow tubular element and may extend as a tube for its entire length. That is, the inner sheath may consist of a tubular insulating distal portion coupled to a push / pull member such as an elongated (and optionally insulated) wire along with the shaft electrode 212. The needle electrode 216 may have a sharp or pointed distal tip as shown in FIG. 2. Alternatively, the needle electrode 216 may be blunted as required for use within a body lumen, such as a blood vessel, or within the biliary system. The needle electrode 216 may take the form of a single hypotube with a tip cap having an end tip, or may be a crimped or otherwise collapsed hypotube. In some embodiments, a single elongated hypotube is used for the needle electrode. In other embodiments, the needle electrode may be an assembly including a push wire coupled to a distal tip portion.

[0032] Although not shown, the outer sheath 210 may also include a lumen for fluid injection out of the distal end of the sheath 210, through the inner sheath 214, or through one or more side openings (not shown). Fluids may be injected into tissues with relatively poor water content (such as the prostate) to, for example, assist ion flow during therapy delivery, to reduce local impedance, or to inject dyes, drugs, or biological materials into the target area. The outer sheath 210 and / or the inner sheath 214 may include one or more fluid passage lumens for aspirating fluid before, during, or after a procedure, as needed. The needle electrode 216 may also include a lumen through its interior to allow fluid to be injected.

[0033] In various embodiments, the illustrated components (outer sheath 210, shaft electrode 212, inner sheath 214, and needle electrode 216) can be advanced and retracted relative to one another. Thus, for example, and not by way of limitation, in use, each of the shaft electrode 212, inner sheath 214, and needle electrode 216 can be advanced to a target area while retracted within the outer sheath 210, and then advanced therefrom individually or in unison (or in stages). Once so positioned, any of the needle electrode 216, inner sheath 214, and shaft electrode 212 can be advanced or retracted relative to the outer sheath 210 as needed, and without the need to move other components. Additionally, the outer sheath 210 can also be advanced over other elements as needed. As a result, the exposed surface area of ​​the shaft electrode 212 can be controlled or manipulated by advancing or retracting the outer sheath 210 relative to the shaft electrode 212 and / or by advancing or retracting the shaft electrode relative to the outer sheath. Similarly, the exposed surface area of ​​the needle electrode 216 can be controlled or manipulated by advancing or retracting the inner sheath 214 relative to the needle electrode 216 and / or by advancing or retracting the needle electrode relative to the inner sheath 214. Finally, the distance between the exposed area of ​​the needle electrode 216 and the shaft electrode 212 can also be manipulated by advancing or retracting the needle electrode 216 relative to the shaft electrode 212 and / or by advancing or retracting the shaft electrode 212 relative to the needle electrode 216.

[0034] Additionally, in some embodiments, the elements can be selectively locked together for the movements described above. In one embodiment, the outer sheath 210 is locked in position relative to the shaft electrode 212 using a proximal locking device (FIGS. 8, 9 below) and / or the inner sheath 214 is locked in position relative to the needle electrode using a proximal locking device (FIGS. 8, 9 below), thereby fixing the exposed areas of each electrode while still allowing relative movement between them.

[0035] The manipulation of electrode size and spacing is described with reference to Figures 2-4. In Figure 2, a first relative positioning and spacing is shown. Figure 3 shows the advancement of the needle electrode 216 relative to the inner sheath 214 exposing more of the surface area of ​​the needle electrode 216 and advancing the needle electrode 216 into the tissue, as well as the outer sheath 210 and shaft electrode 212. In Figure 4, compared to Figure 2, each of the needle electrode 216, inner sheath 214, and shaft electrode 212 have been advanced relative to the outer sheath 210. Comparing Figure 4 to Figure 3, it can be seen that the needle electrode and outer sheath are juxtaposed in the same way in the two figures, but the inner sheath 214 and shaft electrode 212 have both been advanced relative to the needle electrode 216 and outer sheath 210.

[0036] In some examples, the ablation generator can be configured to control the treatment to take into account impedance and temperature. For example, a microcontroller can be used to measure tissue impedance by monitoring the voltage between a pair of treatment generating electrodes and the current flowing between them. As described above, a temperature sensor can be used to keep track of temperature. Thus, during use, the ablation generator can be configured to sense the impedance between the needle electrode and the shaft electrode during treatment delivery, can be configured to obtain a temperature signal from the temperature sensor, and can be further configured to adjust the treatment voltage in response to the temperature and impedance signals. In a use example, at the start of treatment output, the signal generator senses the temperature and impedance and maintains or increases the voltage until the sensed temperature reaches a temperature threshold. Alternatively, the pulse width or pulse repetition rate, or duty cycle, can be increased separately or together with the voltage until the sensed temperature reaches a temperature threshold. The signal generator can be configured to continue to measure the impedance and voltage, and store the target current once the sensed temperature reaches the temperature threshold. The signal generator can then monitor the impedance to maintain the target current after the temperature threshold is reached. If the sensed temperature rises above a temperature threshold, the signal generator can reduce the target current. Such action by the signal generator can be performed to maintain selected ablation conditions while manipulating the surface area and / or location of the electrodes.

[0037] In some embodiments, reconfiguration or manipulation of the surface area and / or positioning of the electrodes can be performed as part of a treatment plan. During delivery of a bipolar treatment, including a thermal ablation treatment, the site of thermal ablation tends to be closest to whichever pole of the treatment output electrode has the smaller surface area. This is because the current density near the smaller electrode is higher, and higher current density produces higher temperatures. As a result, manipulating the exposed surface area of ​​the electrodes between thermal ablation steps can be used to focus the ablation treatment to specific locations. Figures 5-7 show exemplary ablation steps that highlight this capability.

[0038] 5-7 illustrate the steps of the ablation procedure and show the resulting lesion. In these figures, tissue samples 300, 330, 350 are shown dissected after delivery of ablation therapy using the ablation probe. The figures are based on tests performed using liver tissue. The ablation probe is similar to that shown in FIGS. 2-4, having an outer sheath 310, a shaft electrode 312, an inner sheath 314, and a needle electrode 316, each of which is movable relative to one another as described above. In FIG. 5, before delivering the ablation power, the portions of the ablation probe are manipulated so that the exposed surface area of ​​the shaft electrode 312 is smaller than the exposed surface area of ​​the needle electrode 316. When the RF ablation therapy is enabled, the resulting lesion 302 will occur near and adjacent to the shaft electrode 312, since the current density in this volume of tissue is greatest. Higher current density results in greater localized heating. In Figure 6, before delivering ablation power, the portions of the ablation probe are manipulated so that the exposed surface area of ​​the shaft electrode 312 is approximately the same as the exposed surface area of ​​the needle electrode 316. The resulting lesion 332 is more elongated due to a more consistent current density in the volume between the electrodes. In Figure 7, before delivering ablation power, the portions of the ablation probe are manipulated so that the exposed surface area of ​​the shaft electrode 312 is greater than the exposed surface area of ​​the needle electrode 316. The resulting lesion 352 is adjacent to the needle electrode 316. Again, the location of the lesion 352 is the result of an increased current density near the smaller surface area electrode, in this case the needle electrode 316.

[0039] The phrase "about the same" as used to describe FIG. 6 may mean within a range of + / - 10%, or + / - 5%, or + / - 2%, or + / - 1% in some example implementations. This may be contrasted with "less than" or "greater than" as used in the examples of FIGs. 5 and 7, which may mean a difference of more than 10%, or more than 20%, or more than 33%, or more than 50%. Note that to achieve the lesion of FIG. 6, in contrast to the lesions of FIGs. 5 and 7, the output amplitude or pulse width may be higher or the treatment may be delivered for a longer period of time to raise a larger volume of tissue to the required temperature (50-100°C, 55-80°C, 60-70°C, etc.).

[0040] Some embodiments may include performing an ablation step as illustrated by FIG. 6 and then manipulating the ablation probe 310 by moving one or more of the outer sheath 310, shaft electrode 312, inner sheath 314, and / or needle electrode 312 to adjust the relative surface areas of the needle electrode 316 and shaft electrode 312. For example, after forming the elongated lesion of FIG. 6, a more localized lesion adjacent each electrode 312, 316 may be subsequently created using the configuration of FIG. 5 and then the configuration of FIG. 7. In another embodiment, the localized lesions of FIG. 5 and FIG. 7 are first created, followed by the elongated lesion of FIG. 6. In yet other embodiments, the lesion shown in FIG. 6 may be first created, followed by the lesion of FIG. 7, or the lesion of FIG. 7 may be first created, followed by the lesion of FIG. 6. Any such ordering or permutation may be performed as desired.

[0041] In yet other embodiments, the different lesions formed can be formed using different modalities. For example, an IRE-type waveform with a shorter pulse width and higher amplitude can be used first to form a lesion as shown in Figure 6, followed by a RF ablation waveform with a longer pulse width and smaller amplitude to form the lesions of Figures 5 and / or 7. The difference between IRE and RF is not minor; IRE can use pulse widths that are 1-3 orders of magnitude smaller than those of RF, and the amplitude for IRE can be, for example, 2-4 times that of RF.

[0042] Considering in vivo electroporation of liver tissue as an example, the threshold field strength for reversible electroporation can be about 360 V / cm, and the threshold field strength for irreversible electroporation can be about 680 V / cm, as described in U.S. Pat. No. 8,048,067. Electric fields for electroporation have typically been applied by delivering a series of individual pulses, each having a duration ranging from tens to hundreds of microseconds. For example, U.S. Pat. No. 8,048,067 describes a series of eight 100 microsecond pulses delivered one second apart. The '067 patent describes analysis and experiments that were performed to show that the region between lines 20 and 30 in FIG. 1 does in fact exist, and that a non-thermal IRE method is achievable.

[0043] Tissue membranes do not recover instantly from being perforated. As a result, the application of pulses close together in time can have a cumulative effect, as described, for example, in U.S. Patent No. 8,926,606. Furthermore, a series of pulses can be used to first perforate cell membranes and then translocate large molecules through the reversible pores created, as described in U.S. Patent Application Publication No. 2007 / 0025919.

[0044] Although U.S. Patent No. 8,048,067 discusses performing IRE without thermal effects and U.S. Patent No. 8,926,606 discusses using the cumulative effect of closely spaced pulses to achieve IRE, the present invention is directed to combination therapies in some embodiments. For example, a single device using any one output circuit with programmable or reconfigurable features, or a single device with multiple output circuits tuned to different regions (in terms of voltage, pulse width, or other parameters), can be used to deliver both thermal and non-thermal ablation therapies in a tailored manner.

[0045] In one embodiment, the IRE field is generated as one treatment in a series of pulses (e.g., eight pulses of 100 microsecond duration at 800 volts per centimeter delivered at approximately 1 Hz) that precede or follow the thermal ablation output (e.g., eight pulses of 10 millisecond duration at 300 volts per centimeter delivered at approximately 10 Hz). Other combinations and sequences may also be used.

[0046] IRE can be delivered as a series of 1-1000 pulses with durations ranging from 0.1-100 microseconds (or longer) at frequencies ranging from 1-100 Hz (or higher or lower), for example, 8-10 pulses of 5 microsecond duration at 10 Hz. The voltage selected for IRE may be above the IRE threshold (as mentioned above, for liver tissue, the IRE threshold may be in the range of 680 V / cm), but the voltage used may be lower if necessary, assuming that closely spaced pulses can have a cumulative effect. Thermal ablation, on the other hand, can use relatively long pulse widths (100 microseconds or more, typically 1 millisecond or more) and any voltage suitable for a particular application. Thermal ablation can use, for example, relatively lower voltages than IRE, but longer pulse widths and / or higher duty cycles. The voltage can be, for example, but not limited to, in the range of 100-500 V / cm, or lower or higher as desired. As used herein, duty cycle refers to the ratio of "on time" (active output) to off time (zero output) for a given treatment while that treatment is in progress. Duty cycle can refer to, for example, the first pulse of a programmed treatment output to the last pulse of a programmed treatment output, including bursts of treatment output and the rest times between those bursts.

[0047] For the purposes of this description, an "IRE" treatment step is one that primarily uses IRE to cause cell death, although it may have a thermal effect as well; similarly, the primary mode of cell death for a "thermal" treatment step will be thermal, although in some cells IRE may occur as well. Factors that may distinguish a thermal treatment from an IRE treatment may include duty cycle and electric field strength or amplitude. Determination of whether a thermal or IRE treatment was effective may be determined through staining using immunohistochemistry assays, which account for the distinction between tissue regions that have undergone different types of cell death. For example, the immune response to cell death caused by IRE may be distinguishable from the immune response to cells that have been thermally destroyed, and surviving cells and / or cells that have only undergone reversible electroporation may be further distinguished.

[0048] In some embodiments, a monopolar treatment mode is used for thermal ablation using a lower voltage gradient, and a bipolar treatment mode is used for IRE using a higher voltage gradient. IRE treatment can use monophasic or biphasic (or triphasic or other polyphasic) electrical output generated at a relatively low duty cycle (e.g., 1-100 Hz repetition rate, and therefore a duty cycle of less than 0.1%), relatively high amplitude (e.g., producing a field of more than 600 V / cm) and short pulse width (e.g., in the range of 0.1-100 microseconds), thereby avoiding thermal heating and producing primarily IRE treatment. This treatment may include injection of a fluid to enhance or modify the efficacy or spatial effect of the applied electrical treatment, or may instead be injection of an ablation fluid, such as a fluid with limited caustic or cooling or heating effect.

[0049] Thermal ablation can incorporate relatively high duty cycles (such as by applying pulses at frequencies between 10 Hz and 100 kHz to produce a duty cycle greater than 0.1% in some embodiments), longer pulse widths (e.g., between 10 microseconds and 100 milliseconds), and somewhat lower pulse amplitudes (e.g., electric fields less than 600 V / cm). For example, the current can be increased for a given output voltage by injecting saline to reduce local tissue impedance so that both electrical power and fluid are delivered. Although various numerical examples are given herein, the invention can be implemented using not only the ranges disclosed for IRE or thermal ablation, but other ranges unless otherwise specified in the corresponding claims.

[0050] 8 and 9 show additional ablation procedure steps with additional details on the proximal end of the ablation probe. Referring to FIG. 8, a procedure is shown in which the probe, i.e., at least the needle electrode 416, is retracted in stages. Here, the ablation probe is shown with an outer sheath 410, a shaft electrode 412, an inner sheath 414, and a needle electrode 416. The proximal end of the ablation probe is shown with several mechanical stops available for manual actuation. A first stop 420 can be used to fix the relative position of the outer sheath 410 and the shaft electrode, a second stop 422 can be used to fix the relative position of the shaft electrode and the inner sheath 414, and a third stop can be used to fix the relative position of the inner sheath 414 to the needle 416. Such fixation can be used in any of the procedures disclosed herein.

[0051] One particular use of fixation is shown in FIG. 8. Here, a portion of the ablation probe is retracted in a stepwise fashion, as indicated by arrow 430. A first lesion 406 is created in a first ablation step. Before the first ablation step, the ablation probe is manipulated such that the surface area of ​​the shaft electrode 412 is larger than the surface area of ​​the needle electrode 416. The resulting lesion 406 is located at the needle electrode 416. Stops 420 and 424 are actuated by the physician to fix the exposed surface area of ​​the shaft electrode 412 and the exposed surface area of ​​the needle electrode 416, respectively. Here, it is not necessary to actuate stop 422. After the first lesion 406 is created, the combination of the needle electrode 416 and the inner sheath 414 is retracted a desired distance, while the outer sheath 410 and the shaft electrode 412 remain in place. A second ablation output is generated, resulting in a second lesion 404. The process is repeated to form a third lesion at 402. More lesions can be formed as desired.

[0052] The signal generator 440 can be configured to adjust one or more parameters of the output energy as each successive lesion is created, such as by reducing the pulse width, pulse repetition rate, amplitude, or treatment duration. Such adjustments can optionally be included to account for the decrease in distance between the needle electrode 416 and the shaft electrode 412 for each successive treatment. This process can also be performed in reverse order, if desired. Rather than a stepwise process with separate lesions, the user can instead create one elongated lesion by sequentially retracting the needle electrode and inner sheath. As shown in this figure, the signal generator 440 can be electrically coupled to the electrodes 412, 416. Also shown in this figure is a temperature sensor at 418 positioned between the electrodes 412, 416. In other examples, the temperature sensor 418 can be internal to the ablation probe and / or coupled to either one of the electrodes 412, 416, and more than one temperature sensor can be provided, if desired.

[0053] As mentioned above, the signal generator 440 can be configured to maintain a selected temperature within the treatment region, such as by using a temperature sensor placed between the two treatment-generating electrodes (in bipolar mode) or near the active electrode (rather than the indifferent electrode for monopolar mode). The signal generator can then adjust the treatment output to maintain a constant current at the target current level, while using the temperature sensor output to modify that target current level up or down to maintain the target temperature.

[0054] The signal generator 440 can also be configured to obtain data from the ablation probe, which indicates how much of the surface area of ​​each electrode is exposed, as well as how far apart the electrodes are. The signal generator can then adjust its interpretation of the impedance data. For example, if more of the electrode surface area is exposed, the impedance is expected to drop because there is a larger electrode-tissue interface, and vice versa. Furthermore, if the electrodes are farther apart, the impedance is expected to increase. Thus, for example, if the signal generator observes a change in the current generated while the voltage is held constant, the signal generator can distinguish between a change in tissue impedance due to tissue being ablated and a change in impedance due to manipulation of the electrode position. If the tissue impedance changes (such as by dropping) without a change in electrode size or position, the signal generator can treat this as an indication of treatment progress. On the other hand, if the tissue impedance changes with a change in electrode size or position, the signal generator can treat this as not an indication of treatment progress, assuming that the change in impedance is consistent with a change in electrode size or position.

[0055] By way of further explanation, an ablation probe may include one or more potentiometers or other structures therein that change (resistive) impedance under physical manipulation. In another example, parallel plates separated by a dielectric may be provided within the ablation probe, and as the plates are moved by manipulation of electrode size or distance, the capacitance of the parallel plates changes, allowing a signal generator to detect the changing electrode configuration. Thus, for example, plates may be located near the proximal ends of the inner or outer sheaths and / or needles for such use.

[0056] In another embodiment, all of the locking mechanisms can be enabled and the entire ablation probe can be moved between successive ablation treatment outputs. In yet another embodiment, all of the locking mechanisms can be enabled and the entire ablation probe can be withdrawn in a sequential manner as a method of ablation during withdrawal to prevent pathway seeding. Pathway seeding can occur when malignant but still viable cells attach to the ablation probe and then shed from the ablation probe in the pathway as it is withdrawn, effectively turning the treatment device into a tumor spreader. Studies of pathway seeding rates with existing probes have estimated that it occurs in more than 1% of cases, so steps and devices that can prevent pathway seeding are of interest.

[0057] The locking mechanisms 420, 422, 424 may include, for example, threaded screws that tighten the elements to be secured together or fasteners at / near the proximal ends of the elements to be secured. If desired, visual indicators may be provided to allow the user / surgeon to determine the relative spacing at the distal end of the ablation probe. For example, numbered indicators may be provided to indicate the surface area exposed at a given location.

[0058] 9 shows another embodiment. Here, the ablation probe again has an outer sheath 410, a shaft electrode 412, an inner sheath 414, and a needle electrode 416. A proximal manifold 450 is included in this embodiment and may include, for example, a slider 452 for controlling the relative positions of the various parts of the catheter at the distal end. Visual markings 454 may be provided on the manifold 450. The markings may indicate actual positions or may indicate relative surface area exposure (at least for the electrodes 412, 416). In other embodiments, there may be automatic or robotic control on the manifold 450. In some embodiments, the manifold 450 may include sensors for calculating the relative positions of the electrodes and their corresponding surface areas, and communicate such data to an associated signal generator. The signal generator may then calibrate the output power to account for the available surface area and impedance. For example, the signal generator may have data regarding exposed surface area and impedance, and / or distance between electrodes, and may prevent current flow from exceeding prescribed limits to limit uncontrolled diffusion, arcing, etc.

[0059] In use, as shown, multiple lesions can be created as the needle electrode 416 advances from the ablation probe as indicated by arrow 432. The needle electrode 416 can be advanced alone or in combination with one or more of the inner sheath 414, shaft electrode 412, and / or outer sheath 410 as desired. In some embodiments, the needle electrode 416 and inner sheath 414 are locked together during advancement to fix or hold constant the area of ​​the needle electrode 416 that is exposed. In some embodiments, the entire device can be advanced together such that the exposed area of ​​the electrodes 412, 416 remains fixed and the spacing between the two electrodes also remains fixed. In other examples, the surface area of ​​each electrode can remain fixed, but the spacing between them can be varied, and the signal generator can adjust its output, such as by increasing one or more of the power, amplitude (voltage or current), pulse width, or pulse repetition rate as the spacing increases, or by decreasing one or more of the power (voltage or current), amplitude, pulse width, or pulse repetition rate as the spacing decreases. Such increase / decrease may be linear with respect to the distance between the electrodes, or may follow a more complex pattern, such as increasing with the square of the distance. For example, to maintain a constant current as the distance increases, the voltage will increase or decrease in direct proportion to the distance, whereas to maintain constant power, the voltage will increase or decrease in proportion to the square of the distance.

[0060] 10 and 11 are process flow diagrams in block form for an exemplary ablation procedure. FIG. 10 shows one exemplary method. Here, a probe is positioned at a desired location in step 500. Step 500 may include advancing the ablation probe over a guidewire, i.e., with the aid of a guidewire, through an incision toward the target tissue. Advancement may proceed through a body lumen (such as in a blood vessel, a breast duct or other duct, a section of the biliary system, a portion of the digestive tract, the esophagus or trachea, a renal duct, a urethra, or other passageway), in some embodiments, while the probe advances through the tissue without using any such body lumen or anatomical passageway. With the ablation probe positioned, in step 502, one or more electrodes may be advanced to the target tissue. As shown in 504, the surface area of ​​one or more electrode surfaces is manipulated, block 504 is shown after step 502, although the two may be interchanged if desired. The treatment is then output, as shown in 506. The procedure may loop back to step 502 with movement of one or more electrodes and / or step 504 with manipulation of the surface area of ​​one or more electrodes, as shown, as needed. For example, a lesion as in Figure 5 may be formed first, then a lesion as in Figure 6 or 7 may be performed, or in any other suitable order.

[0061] FIG. 11 illustrates another embodiment, where an ablation probe is again placed with or without the use of a body lumen or anatomical passageway at 550. An electrode is advanced as shown at 552. One or more surface areas of the electrodes are manipulated at 554 to achieve a desired relative surface area exposure. Therapy is then delivered as shown at 556. In the embodiment of FIG. 11, while the therapy is occurring, one or more of the electrodes used to output the therapy are moved as well. This may include advancing or retracting the needle electrode, shaft electrode, or both, as needed. Again, the procedure may loop back to block 552 and / or block 554 for further ablation steps.

[0062] Each of these non-limiting examples can exist alone or can be combined with one or more of the other examples in various permutations or combinations. The above Detailed Description includes reference to the accompanying drawings, which form a part of the Detailed Description. The drawings show, by way of example, certain embodiments. These embodiments are also referred to herein as "examples." Such examples may include elements other than those shown. The inventors also contemplate examples in which only those elements shown or described are provided. Moreover, the inventors also contemplate examples using any combination or permutation of those elements (or one or more aspects thereof) shown or described with respect to a particular example (or one or more aspects thereof), or with respect to other examples (or one or more aspects thereof) shown or described herein.

[0063] In the event of a conflict in usage between this document and any document so incorporated by reference, the usage in this document shall control. In this document, the terms "a" or "an" are used, as is common in patent documents, to include one or more, regardless of any other instance or usage of "at least one" or "one or more." Furthermore, in the claims, terms such as "first," "second," and "third" are used merely as labels and are not intended to impose numerical requirements on their objects.

[0064] The method embodiments described herein may be at least partially machine or computer implemented. Some embodiments may include a computer readable medium or machine readable medium encoded with instructions operable to configure an electronic device to perform the method as described in the above embodiments. Such method implementations may include code, such as microcode, assembly language code, higher level language code, etc. Such code may include computer readable instructions for performing various methods. The code may form parts of a computer program product. Furthermore, in one embodiment, the code may be tangibly stored on one or more volatile, non-transitory, or non-volatile tangible computer readable media, such as during execution or at other times. Examples of these tangible computer readable media may include, but are not limited to, hard disks, removable magnetic or optical disks, magnetic cassettes, memory cards or sticks, random access memory (RAM), read only memory (ROM), etc.

[0065] The above description is intended to be illustrative, and not restrictive. For example, the above-described examples (or one or more aspects thereof) can be used in combination with each other. Other embodiments can also be used, such as by one of ordinary skill in the art reviewing the above description. The Abstract is provided in accordance with 37 U.S.C. § 1.72(b) to allow the reader to quickly ascertain the nature of the technical disclosure. The Abstract is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the claims.

[0066] Also, in the above Detailed Description, various features may be grouped together to streamline the disclosure. This should not be construed as intending that an unclaimed disclosed feature is essential to any claim. Rather, innovative subject matter may reside in less than all features of a particular disclosed embodiment. Thus, the following claims are hereby incorporated into the Detailed Description as an example or embodiment, with each claim standing on its own as a separate embodiment, and such embodiments can be combined with each other in various combinations or permutations. The scope of protection should be determined with reference to the appended claims, along with the full scope of equivalents to which such claims are entitled.

Claims

1. 1. An ablation probe having a proximal end and a distal end, the ablation probe comprising: an outer sheath of a non-conductive material; an inner sheath of a non-conductive material; a shaft electrode disposed between the inner sheath and the outer sheath; a needle electrode disposed within the inner sheath; a first locking hub configured to selectively lock a relative position of the outer sheath with respect to the shaft electrode; a second locking hub configured to selectively lock the relative position of the shaft electrode with respect to the inner sheath; a third locking hub configured to selectively lock the relative position of the inner sheath with respect to the needle electrode.

2. 2. The ablation probe of claim 1, wherein the needle electrode, the inner sheath, the shaft electrode, and the outer sheath are movable relative to one another when each is not locked to any of the first to third locking hubs.

3. The ablation probe of claim 1 or 2, wherein the needle electrode includes a tissue-piercing distal tip.

4. 4. The ablation probe of claim 1, wherein the third locking hub facilitates the step of defining an exposed surface area of ​​the needle electrode and the first locking hub facilitates the step of defining an exposed surface area of ​​the shaft electrode such that, in use, a user can lock the first locking hub and the third locking hub while moving the needle electrode, having a fixed surface area, relative to the shaft electrode, also having a fixed surface area.

5. 5. A system for ablation comprising the ablation probe of claim 4 and a signal generator adapted for electrical connection to each of the needle electrode and the shaft electrode, the signal generator configured to sense impedance between the needle electrode and the shaft electrode during treatment delivery to maintain a treatment current as the needle electrode and the shaft electrode are moved relative to one another.

6. The ablation probe of claim 1 , further comprising a temperature sensor associated with at least one of the shaft electrode or the needle electrode.

7. 7. A system for ablation comprising the ablation probe of claim 6 and a signal generator adapted for electrical connection to each of the needle electrode and the shaft electrode, the signal generator configured to sense impedance between the needle electrode and the shaft electrode during treatment delivery, configured to acquire a temperature signal from the temperature sensor, and configured to adjust a treatment voltage in response to the temperature signal and the impedance signal.

8. The signal generator Sensing temperature and impedance at the initiation of therapy output; maintaining or increasing the voltage until the sensed temperature reaches a temperature threshold; measuring impedance and voltage and storing a target current when the sensed temperature reaches the temperature threshold; monitoring impedance to maintain the target current after the temperature threshold is reached; and operable to reduce the target current if the sensed temperature rises above the temperature threshold. The system of claim 7 configured to:

9. 9. The system of claim 7 or 8, wherein the signal generator is configured to sense the distance between the electrodes and the surface area of ​​the electrodes by linking to either locking hub.

10. The system of claim 9 , wherein the signal generator is configured to adjust the sensed impedance to take into account the distance between the electrodes and / or the surface area of ​​the electrodes.

11. The system of any one of claims 5 or 7-10, wherein the signal generator is configured to provide ablation signals for irreversible electroporation and thermal ablation.

12. The ablation probe of any one of claims 1 to 4 or 6, further comprising means for electrically indicating a change in exposed surface area of ​​at least one of the shaft electrode and the needle electrode.

13. The ablation probe of any one of claims 1 to 4, 6 or 12, further comprising means for electrically indicating a change in distance between the shaft electrode and the needle electrode.

14. The ablation probe of any one of claims 1 to 4, 6, 12 or 13, wherein the needle electrode comprises a lumen passing through an interior of the needle electrode to allow fluid to be injected therethrough.

15. The ablation probe of any one of claims 1-4, 6, or 12, 13, wherein the outer sheath includes a lumen passing through an interior of the outer sheath to allow fluid to be infused.

Citation Information

Patent Citations

  • Dual-electrode probe and operation method thereof

    CN111529049A

  • Electrosurgical instrument for use in e.g. myoma necrosis

    DE19713797A1

  • Applicator for hyperthermia

    JP1998277163A

  • Puncture treatment apparatus

    JP1999332880A

  • Ablation device

    JP2012170777A